Pages that link to "Q37316222"
Jump to navigation
Jump to search
The following pages link to Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? (Q37316222):
Displaying 50 items.
- Clinical and molecular complexity of breast cancer metastases (Q26796326) (← links)
- Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer (Q27852937) (← links)
- Improving systemic breast cancer therapy: time to look beyond the primary tumour? (Q28078275) (← links)
- Metastatic breast cancer or multiple myeloma? Camouflage by lytic lesions (Q33708330) (← links)
- PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer (Q33715936) (← links)
- Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives (Q33738675) (← links)
- Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis. (Q33777431) (← links)
- Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline (Q33817285) (← links)
- Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. (Q33917455) (← links)
- Circulating tumor cells predict survival in early average-to-high risk breast cancer patients (Q33958981) (← links)
- Case Report of Pulmonary Sarcoidosis Suspected to be Pulmonary Metastasis in a Patient with Breast Cancer (Q34043409) (← links)
- The effect of surveillance on the outcome of breast cancer patients (Q34082340) (← links)
- Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Position Emission Tomography Imaging Agent (Q34111208) (← links)
- Herceptin functionalized microfluidic polydimethylsiloxane devices for the capture of human epidermal growth factor receptor 2 positive circulating breast cancer cells. (Q34256705) (← links)
- Role of lapatinib in the first-line treatment of patients with metastatic breast cancer. (Q34417920) (← links)
- St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial (Q34463987) (← links)
- The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer (Q34569318) (← links)
- Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS). (Q34613506) (← links)
- The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases (Q34696334) (← links)
- Comparison of hormone receptor status in primary and recurrent breast cancer (Q34987082) (← links)
- Receptor conversion in distant breast cancer metastases (Q34989060) (← links)
- The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients (Q35009047) (← links)
- Gene signatures of breast cancer progression and metastasis. (Q35029477) (← links)
- Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss (Q35082619) (← links)
- Adaptive changes result in activation of alternate signaling pathways and acquisition of resistance to aromatase inhibitors (Q35091502) (← links)
- Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker (Q35519793) (← links)
- A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation (Q35538013) (← links)
- Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis (Q35546265) (← links)
- A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer (Q35563020) (← links)
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis (Q35583809) (← links)
- Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study (Q35683537) (← links)
- Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study (Q35690804) (← links)
- Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor (Q35776216) (← links)
- Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors (Q35808400) (← links)
- Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients (Q35836555) (← links)
- Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients (Q36085375) (← links)
- Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series (Q36138028) (← links)
- Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions (Q36292201) (← links)
- Metastatic gastric carcinoma from breast cancer mimicking primary linitis plastica: A case report (Q36335765) (← links)
- Testing for her2 in breast cancer: current pathology challenges faced in Canada. (Q36416223) (← links)
- Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer. (Q36471883) (← links)
- Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications (Q36545146) (← links)
- Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified. (Q36584362) (← links)
- Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study (Q36756659) (← links)
- Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. (Q36924473) (← links)
- Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines (Q37120795) (← links)
- Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer (Q37240839) (← links)
- Breast Cancer Biomarkers: Utility in Clinical Practice (Q37441159) (← links)
- Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study (Q37534923) (← links)
- Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients (Q37544396) (← links)